Literature DB >> 36264155

Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan.

Nid'a Alshraiedeh1, Farah Atawneh2, Rasha Bani-Salameh2, Rawan Alsharedeh3, Yara Al Tall1, Mohammad Alsaggar1.   

Abstract

BACKGROUND: Notable emergence of multidrug-resistant bacteria has become increasingly problematic worldwide. Most patients with cystic fibrosis (CF) suffer from chronic persistent infections with frequent occurrence of acute exacerbations. Routine screening of bacterial strains, epidemiological characteristics, and resistance patterns are particularly useful for patient management and maintenance of infection control procedures.
METHODS: In this study, 43 pharyngeal samples were taken from patients with CF. Microbiological bacterial culture and identification, antimicrobial susceptibility testings, biofilm formation, including minimum biofilm eradication concentration (MBEC) and PCR for detecting resistance genes were performed.
RESULTS: All samples were positive for bacterial growth. The predominant species were Staphylococcus aureus (41.86%; n = 18) and Pseudomonas aeruginosa (39.53%; n = 17). 30% of isolated bacteria were multidrug-resistant, resisting high concentrations of tested antibiotics. Among the 42 biofilm-forming isolates, 23.8% (n = 10) were strong biofilm formers. The occurance of resistance genes varied with blaKPC detected in 71% (n = 17) of all Gram-negative isolates and mecA found in 61% (n = 11) of all S. aureus strains.
CONCLUSIONS: The majority of isolated bacteria were S. aureus and P. aeruginosa. The high frequency of antimicrobial resistance, the presence of resistance genes, and biofilm formation highlight the challenge in treatment and infection control measures in patients with CF.KEY MESSAGESStaphylococcus aureus and Pseudomonas aeruginosa are the most prevalent pathogens found in patients with CF in Jordan.Detection of antimicrobial resistance genes in patients with CF confirms that antimicrobial resistance patterns must always be monitored.Biofilm formation significantly increases the tolerance of bacteria to antimicrobial agents.

Entities:  

Keywords:  Antimicrobial resistance; antimicrobial resistance genes; biofilm; cystic fibrosis

Mesh:

Substances:

Year:  2022        PMID: 36264155      PMCID: PMC9586617          DOI: 10.1080/07853890.2022.2131282

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   5.348


  25 in total

1.  Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing.

Authors:  Isamu Nakasone; Tohru Kinjo; Nobuhisa Yamane; Kyoko Kisanuki; Chika M Shiohira
Journal:  Diagn Microbiol Infect Dis       Date:  2007-02-14       Impact factor: 2.803

Review 2.  Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Juan P Horcajada; Milagro Montero; Antonio Oliver; Luisa Sorlí; Sònia Luque; Silvia Gómez-Zorrilla; Natividad Benito; Santiago Grau
Journal:  Clin Microbiol Rev       Date:  2019-08-28       Impact factor: 26.132

3.  Airway mucus in cystic fibrosis.

Authors:  Edith Puchelle; Odile Bajolet; Michel Abély
Journal:  Paediatr Respir Rev       Date:  2002-06       Impact factor: 2.726

4.  Antibiotic Susceptibility and Biofilm Formation of Bacterial Isolates Derived from Pediatric Patients with Cystic Fibrosis from Tehran, Iran.

Authors:  M Kodori; B Nikmanesh; H Hakimi; Z Ghalavand
Journal:  Arch Razi Inst       Date:  2021-07-01

5.  Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.

Authors:  Parisa Vali; Fereshteh Shahcheraghi; Maryam Seyfipour; Maryam Alsadat Zamani; Mohammad Reza Allahyar; Mohammad Mehdi Feizabadi
Journal:  J Clin Diagn Res       Date:  2014-01-12

6.  Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil.

Authors:  Maria Angélica Santana; Eliana Matos; Maria do Socorro Fontoura; Rosana Franco; Danyella Barreto; Antônio Carlos M Lemos
Journal:  Braz J Infect Dis       Date:  2003-02       Impact factor: 1.949

7.  National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.

Authors:  A Vergison; O Denis; A Deplano; G Casimir; G Claeys; F DeBaets; K DeBoeck; N Douat; H Franckx; J Gigi; M Ieven; C Knoop; P Lebeque; F Lebrun; A Malfroot; F Paucquay; D Pierard; J Van Eldere; M J Struelens
Journal:  J Antimicrob Chemother       Date:  2007-03-06       Impact factor: 5.790

8.  Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.

Authors:  Fadi Bittar; Hervé Richet; Jean-Christophe Dubus; Martine Reynaud-Gaubert; Nathalie Stremler; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

9.  Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa.

Authors:  John Y Bolukaoto; Charles M Monyama; Martina O Chukwu; Sebotse M Lekala; Maphoshane Nchabeleng; Motlatji R B Maloba; Rooyen T Mavenyengwa; Sogolo L Lebelo; Sam T Monokoane; Charles Tshepuwane; Sylvester R Moyo
Journal:  BMC Res Notes       Date:  2015-08-20

10.  Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae.

Authors:  Samer Swedan; Zaina Shubair; Ammar Almaaytah
Journal:  Infect Drug Resist       Date:  2019-07-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.